Clinical trial Recruiting at 1 site Observational Ages 18 and up

Evaluating treatment outcomes for pancreatic diseases

Official title: Evaluation of Outcomes From Treatment of Benign or Malignant Pancreatic Diseases

Run by Methodist Health System · NCT04055571 · Data updated 2026-11-12

This study looks at how well different treatments work for people with pancreatic diseases to see if they can improve survival and manage symptoms better.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment500 (estimated)
SponsorMethodist Health System
Academic / other
Locations1 site (Richardson, Texas)
StatusRecruiting
StartedMarch 5, 2019
Main results expectedJanuary 30, 2027
Study endsJanuary 30, 2028
Registry record updatedJune 10, 2026
Trial IDNCT04055571 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include adults aged 18 and older who have been diagnosed and treated for benign or malignant pancreatic diseases since 2005.

Probably not a fit

Patients under 18 years old or those not diagnosed with pancreatic diseases will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study involves a retrospective chart review of patients diagnosed with benign or malignant pancreatic diseases treated by Dr. Rohan Jeyarajah, Dr. Houssam Osman, and Dr. Edward Cho at Methodist Health System Hospital in Richardson, TX. The study aims to analyze patient outcomes from 2005 to the present, focusing on improving overall survival, symptom control, and treatment algorithms for pancreatic conditions. Data will be collected from patient records and a national database, with analysis conducted by the study team.

Why it matters

Potential benefit: If successful, this study could lead to improved treatment strategies and better outcomes for patients with pancreatic diseases.

How similar studies have gone: While there is ongoing research in pancreatic disease treatment, this specific observational approach is less common, focusing on retrospective outcomes evaluation.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* • All patients diagnosed and treated for pancreatic diseases, benign or malignant from 2005 to present

  * Age ≥18 years

Exclusion Criteria:

* • Patients that are not diagnosed with or treated for pancreatic diseases

  * Age \< 18 years

Where it's running

  • Trinity Surgical Consultants, Methodist Richardson Medical Center
    Richardson, Texas, United States
    Recruiting

Study contacts

  • Principal investigator: Dhiresh Jeyarajah, M.D. — Methodist Richardson Medical Center
  • Study coordinator: Crystee Cooper, DHEd
  • Email: CrysteeCooper@mhd.com
  • Phone: 214-947-1280

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.